pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
fda medwatch·Aug 24·1 min read
save

FDA alerts to potential fungal contamination in Medline kits containing recalled BD ChloraPrep applicators

Aug 24, 2026·read at fda medwatch ↗RegulatoryNegative

The Center for Devices and Radiological Health (CDRH) has issued an Early Alert to warn the public about a possible high-risk device problem involving Medline convenience kits.

Medline has sent a letter to customers telling them to remove from use and destroy any convenience kits that contain the recalled BD ChloraPrep applicators because of a risk of fungal contamination.

The kits affected are Medline Convenience Kits that include BD ChloraPrep Clear 1 mL single sterile applicators (Item 930480, lot 4032183) and FREPP Clear 1.5 mL applicators with paper lidding (Item 930299, lot 4073005).

Users are instructed to review inventory, quarantine the kits, complete response forms and then destroy the entire kit.

The current guidance supersedes an earlier June 12, 2026 notice that had advised over-labeling the kits; now full destruction is required.

source

This writeup was produced by pharmadog from original reporting by fda medwatch.

Original headline: “Early Alert: Convenience Kit Issue from Medline”

read at fda medwatch ↗
730 words · retrieved Aug 24
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
UNIQUE
topics
Recall6Infectious Disease2Dermatology

related stories

  • Aug 28Early Alert: IV Start Kit Issue from Avid Medicalfda medwatch
  • Aug 24Early Alert: Convenience Kit Issue from AVID Medicalfda medwatch
  • Jul 6Convenience Kit Correction: Windstone Medical Packaging, Inc. Issues Correction for Convenience Kitfda medwatch
  • 1d agoFoghorn cuts 40% of workforceBioSpace
  • Sep 24Convenience Kit Correction: Becton Dickinson Issues Correction for Kits and Procedure Trays Containing Recalled Sodium Chloride Ampulesfda medwatch